Riskpilot← Back to searchSign inGet full accessSVØMMEHALLEN FYSIOTERAPI AS
ASActiveOrg 985537011Moa, 6018 ÅlesundPhysiotherapy activities · NACE 8695Est. 20030 employees
Revenue 2024
NOK 3,3M
+4% vs 2023
EBITDA margin
0.3%
+36% vs 2023
Equity ratio
52.0%
Financial strength
Net profit 2024
NOK 11K
+38% vs 2023
| Revenue | NOK 3,3M | +4% |
| EBITDA | NOK 11K | +36% |
| Net profit | NOK 11K | +38% |
| Total assets | NOK 397K | +100% |
| Equity | NOK 206K | +5% |
| Employees | 0 | — |
Legal name
SVØMMEHALLEN FYSIOTERAPI AS
Org number
985537011
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
2. april 2003
Share capital
NOK 150 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder og ett styremedlem i fellesskap.
Company purpose
Fysioterapivirksomhet og det som naturlig kan knyttes opp mot slik virksomhet.
Address
Moa, 6018 Ålesund
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 599 | 3 071 | 3 055 | 3 157 | 3 296 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 |
| EBITDA | −11 | 163 | 15 | 8 | 11 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | −11 | 163 | 15 | 8 | 11 |
| Net financials | −1 | 0 | 0 | −0 | −0 |
| Profit before tax | −12 | 163 | 15 | 8 | 11 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | −12 | 163 | 15 | 8 | 11 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 133 | 187 | 188 | 198 | 397 |
| Equity | 10 | 173 | 188 | 196 | 206 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 124 | 14 | 0 | 2 | 190 |
| Total debt | 124 | 14 | 0 | 2 | 190 |
EBITDA margin
0.3%
This company
15.8%
Market median
-98% vs market
20202024
Equity ratio
52.0%
This company
38.2%
Market median
+36% vs market
20202024
Return on equity
5.1%
This company
18.4%
Market median
-72% vs market
20202024
Net profit margin
0.3%
This company
8.1%
Market median
-96% vs market
20202024
Asset turnover
8.31×
This company
1.12×
Market median
+642% vs market
20202024
Debt / equity
0.92×
This company
0.62×
Market median
+48% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EU Chief Executive Officer | Chief Executive Officer | 2018 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2021 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 | |
| Individual | 16.67% | 16.67% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SVØMMEHALLEN FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Egil Ulvestad | Chief Executive Officer | 0 companies |
| Helene Sofie Kjersem Hoff | Chairman | 0 companies |